

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of fibrinolysis (GO:0051918) | 9.02378852 |
| 2 | regulation of fibrinolysis (GO:0051917) | 8.95944279 |
| 3 | regulation of protein activation cascade (GO:2000257) | 8.07388517 |
| 4 | regulation of complement activation (GO:0030449) | 7.75076450 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 7.68350853 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.68350853 |
| 7 | complement activation, alternative pathway (GO:0006957) | 7.66370712 |
| 8 | epoxygenase P450 pathway (GO:0019373) | 7.30298356 |
| 9 | exogenous drug catabolic process (GO:0042738) | 7.15703652 |
| 10 | protein carboxylation (GO:0018214) | 7.13140750 |
| 11 | peptidyl-glutamic acid carboxylation (GO:0017187) | 7.13140750 |
| 12 | ethanol oxidation (GO:0006069) | 7.09787896 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.09323441 |
| 14 | L-phenylalanine metabolic process (GO:0006558) | 7.09323441 |
| 15 | omega-hydroxylase P450 pathway (GO:0097267) | 6.88461991 |
| 16 | blood coagulation, intrinsic pathway (GO:0007597) | 6.63642405 |
| 17 | drug catabolic process (GO:0042737) | 6.59254937 |
| 18 | glyoxylate metabolic process (GO:0046487) | 6.48705788 |
| 19 | fibrinolysis (GO:0042730) | 6.13714527 |
| 20 | ethanol metabolic process (GO:0006067) | 5.74177433 |
| 21 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.66362087 |
| 22 | regulation of plasminogen activation (GO:0010755) | 5.62782511 |
| 23 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.56605516 |
| 24 | negative regulation of sterol transport (GO:0032372) | 5.55511002 |
| 25 | negative regulation of cholesterol transport (GO:0032375) | 5.55511002 |
| 26 | aromatic amino acid family catabolic process (GO:0009074) | 5.35687169 |
| 27 | urea metabolic process (GO:0019627) | 5.33768227 |
| 28 | intestinal cholesterol absorption (GO:0030299) | 5.32813287 |
| 29 | plasma lipoprotein particle remodeling (GO:0034369) | 5.29305604 |
| 30 | protein-lipid complex remodeling (GO:0034368) | 5.29305604 |
| 31 | macromolecular complex remodeling (GO:0034367) | 5.29305604 |
| 32 | cholesterol efflux (GO:0033344) | 5.28915598 |
| 33 | cellular glucuronidation (GO:0052695) | 5.21793958 |
| 34 | imidazole-containing compound metabolic process (GO:0052803) | 5.15993949 |
| 35 | protein activation cascade (GO:0072376) | 5.14730806 |
| 36 | negative regulation of protein activation cascade (GO:2000258) | 5.09698718 |
| 37 | plasma lipoprotein particle assembly (GO:0034377) | 5.00765690 |
| 38 | high-density lipoprotein particle remodeling (GO:0034375) | 4.95089579 |
| 39 | regulation of cholesterol esterification (GO:0010872) | 4.94606471 |
| 40 | glucuronate metabolic process (GO:0019585) | 4.92515778 |
| 41 | uronic acid metabolic process (GO:0006063) | 4.92515778 |
| 42 | negative regulation of blood coagulation (GO:0030195) | 4.85646771 |
| 43 | negative regulation of hemostasis (GO:1900047) | 4.85646771 |
| 44 | drug metabolic process (GO:0017144) | 4.83293165 |
| 45 | nitrogen cycle metabolic process (GO:0071941) | 4.82835691 |
| 46 | low-density lipoprotein particle remodeling (GO:0034374) | 4.76546341 |
| 47 | regulation of humoral immune response (GO:0002920) | 4.72706857 |
| 48 | complement activation, classical pathway (GO:0006958) | 4.72493664 |
| 49 | bile acid biosynthetic process (GO:0006699) | 4.72266839 |
| 50 | serine family amino acid catabolic process (GO:0009071) | 4.67439370 |
| 51 | regulation of apoptotic cell clearance (GO:2000425) | 4.65225871 |
| 52 | bile acid metabolic process (GO:0008206) | 4.58354019 |
| 53 | urea cycle (GO:0000050) | 4.56546430 |
| 54 | glutamate metabolic process (GO:0006536) | 4.56469679 |
| 55 | complement activation (GO:0006956) | 4.56090107 |
| 56 | reverse cholesterol transport (GO:0043691) | 4.53102695 |
| 57 | positive regulation of blood coagulation (GO:0030194) | 4.49311220 |
| 58 | positive regulation of hemostasis (GO:1900048) | 4.49311220 |
| 59 | acute-phase response (GO:0006953) | 4.46506591 |
| 60 | plasma lipoprotein particle organization (GO:0071827) | 4.45609464 |
| 61 | protein-lipid complex assembly (GO:0065005) | 4.44483370 |
| 62 | negative regulation of coagulation (GO:0050819) | 4.43377159 |
| 63 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.39756230 |
| 64 | triglyceride homeostasis (GO:0070328) | 4.37813307 |
| 65 | acylglycerol homeostasis (GO:0055090) | 4.37813307 |
| 66 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.37188394 |
| 67 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.37188394 |
| 68 | phospholipid efflux (GO:0033700) | 4.35140722 |
| 69 | oxidative demethylation (GO:0070989) | 4.31793227 |
| 70 | negative regulation of wound healing (GO:0061045) | 4.30285396 |
| 71 | glycine metabolic process (GO:0006544) | 4.27023081 |
| 72 | plasma lipoprotein particle clearance (GO:0034381) | 4.26918855 |
| 73 | negative regulation of complement activation (GO:0045916) | 4.22503963 |
| 74 | tyrosine metabolic process (GO:0006570) | 4.19589685 |
| 75 | protein-lipid complex subunit organization (GO:0071825) | 4.18252818 |
| 76 | cytolysis (GO:0019835) | 4.13775350 |
| 77 | positive regulation of coagulation (GO:0050820) | 4.11460878 |
| 78 | bile acid and bile salt transport (GO:0015721) | 4.09796114 |
| 79 | regulation of triglyceride catabolic process (GO:0010896) | 4.06590868 |
| 80 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.00505911 |
| 81 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.00505911 |
| 82 | negative regulation of lipase activity (GO:0060192) | 3.84537677 |
| 83 | phenylpropanoid metabolic process (GO:0009698) | 3.84280207 |
| 84 | alpha-amino acid catabolic process (GO:1901606) | 3.68786560 |
| 85 | opsonization (GO:0008228) | 3.67132653 |
| 86 | lipoprotein metabolic process (GO:0042157) | 3.59203602 |
| 87 | regulation of bile acid biosynthetic process (GO:0070857) | 3.53669597 |
| 88 | amino-acid betaine metabolic process (GO:0006577) | 3.52988298 |
| 89 | sodium-independent organic anion transport (GO:0043252) | 3.49204925 |
| 90 | serine family amino acid metabolic process (GO:0009069) | 3.45079358 |
| 91 | aromatic amino acid family metabolic process (GO:0009072) | 3.43718536 |
| 92 | proline metabolic process (GO:0006560) | 3.43395809 |
| 93 | intestinal absorption (GO:0050892) | 3.41293895 |
| 94 | cholesterol homeostasis (GO:0042632) | 3.41163605 |
| 95 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.40103893 |
| 96 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.39719234 |
| 97 | sterol transport (GO:0015918) | 3.38403818 |
| 98 | cholesterol transport (GO:0030301) | 3.38403818 |
| 99 | sterol homeostasis (GO:0055092) | 3.36535839 |
| 100 | S-adenosylmethionine metabolic process (GO:0046500) | 3.34450649 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.99953476 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.04268866 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.92376681 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.80909263 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.79407644 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.68195237 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.07802244 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.96767514 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.73652905 |
| 10 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 3.53782734 |
| 11 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.96101833 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.74725845 |
| 13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.29900941 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7919059 |
| 15 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.98066760 |
| 16 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.80201034 |
| 17 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.72197248 |
| 18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.50865653 |
| 19 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.45397367 |
| 20 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.34680873 |
| 21 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.31953274 |
| 22 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.28783993 |
| 23 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.27235019 |
| 24 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.24316748 |
| 25 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.17815538 |
| 26 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.14635140 |
| 27 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.14031481 |
| 28 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.10783844 |
| 29 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.07994289 |
| 30 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.07964587 |
| 31 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.05331475 |
| 32 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.04571761 |
| 33 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.02543986 |
| 34 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.01894844 |
| 35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.01545274 |
| 36 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.00546947 |
| 37 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.99859646 |
| 38 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.99805450 |
| 39 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.99589151 |
| 40 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.99371825 |
| 41 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.94987831 |
| 42 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.92844683 |
| 43 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.92377219 |
| 44 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91025639 |
| 45 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.89699416 |
| 46 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.89379717 |
| 47 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.89195844 |
| 48 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.84968773 |
| 49 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.80499656 |
| 50 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.80407410 |
| 51 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.78515517 |
| 52 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.78288874 |
| 53 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.77418836 |
| 54 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.76780574 |
| 55 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.75349758 |
| 56 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.75113211 |
| 57 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.73061244 |
| 58 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.71469440 |
| 59 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.71092751 |
| 60 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.68850881 |
| 61 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.66534206 |
| 62 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.63963056 |
| 63 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.63778523 |
| 64 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.63684079 |
| 65 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.63548091 |
| 66 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.63138792 |
| 67 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.63049254 |
| 68 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.62242759 |
| 69 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.61230448 |
| 70 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.60782626 |
| 71 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.60583405 |
| 72 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.59797619 |
| 73 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.59211874 |
| 74 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.58963895 |
| 75 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.57036218 |
| 76 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.55150646 |
| 77 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.54903047 |
| 78 | TP53_16413492_ChIP-PET_HCT116_Human | 0.54429845 |
| 79 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.54212907 |
| 80 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.54146349 |
| 81 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.53030515 |
| 82 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.52981335 |
| 83 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.52468743 |
| 84 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.52383384 |
| 85 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.52286191 |
| 86 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.51702011 |
| 87 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.50947997 |
| 88 | AR_20517297_ChIP-Seq_VCAP_Human | 0.50824247 |
| 89 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.50081196 |
| 90 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.49597409 |
| 91 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.49337657 |
| 92 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.49221487 |
| 93 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.48548405 |
| 94 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.48499847 |
| 95 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.48124573 |
| 96 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.47353589 |
| 97 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.47126705 |
| 98 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.46785222 |
| 99 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.46516654 |
| 100 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.46242642 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 9.28835749 |
| 2 | MP0005360_urolithiasis | 6.27504960 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.76112178 |
| 4 | MP0005365_abnormal_bile_salt | 5.62541507 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.56824495 |
| 6 | MP0003195_calcinosis | 5.10347446 |
| 7 | MP0003252_abnormal_bile_duct | 3.92805773 |
| 8 | MP0001666_abnormal_nutrient_absorption | 3.79100805 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.51828132 |
| 10 | MP0003868_abnormal_feces_composition | 3.20948738 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 2.83556863 |
| 12 | MP0009697_abnormal_copulation | 2.33014765 |
| 13 | MP0005332_abnormal_amino_acid | 2.24535153 |
| 14 | MP0003122_maternal_imprinting | 2.22776006 |
| 15 | MP0010368_abnormal_lymphatic_system | 2.10708419 |
| 16 | MP0003806_abnormal_nucleotide_metabolis | 2.05314243 |
| 17 | MP0000609_abnormal_liver_physiology | 1.98927253 |
| 18 | MP0005408_hypopigmentation | 1.84495407 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 1.84030874 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 1.80866841 |
| 21 | MP0009840_abnormal_foam_cell | 1.77365899 |
| 22 | MP0002132_abnormal_respiratory_system | 1.65721610 |
| 23 | MP0002876_abnormal_thyroid_physiology | 1.59682585 |
| 24 | MP0001915_intracranial_hemorrhage | 1.47485044 |
| 25 | MP0005451_abnormal_body_composition | 1.42406124 |
| 26 | MP0001764_abnormal_homeostasis | 1.39526287 |
| 27 | MP0001661_extended_life_span | 1.35127051 |
| 28 | MP0003656_abnormal_erythrocyte_physiolo | 1.30287402 |
| 29 | MP0004019_abnormal_vitamin_homeostasis | 1.17235573 |
| 30 | MP0000598_abnormal_liver_morphology | 1.17208554 |
| 31 | MP0005319_abnormal_enzyme/_coenzyme | 1.08941157 |
| 32 | MP0000566_synostosis | 1.07594741 |
| 33 | MP0002089_abnormal_postnatal_growth/wei | 1.01723729 |
| 34 | MP0005058_abnormal_lysosome_morphology | 1.01466867 |
| 35 | MP0000604_amyloidosis | 0.94282816 |
| 36 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.94005900 |
| 37 | MP0003123_paternal_imprinting | 0.93609502 |
| 38 | MP0009643_abnormal_urine_homeostasis | 0.92425454 |
| 39 | MP0005670_abnormal_white_adipose | 0.92290426 |
| 40 | MP0009642_abnormal_blood_homeostasis | 0.91678144 |
| 41 | MP0005464_abnormal_platelet_physiology | 0.89813579 |
| 42 | MP0003172_abnormal_lysosome_physiology | 0.88421207 |
| 43 | MP0005636_abnormal_mineral_homeostasis | 0.87445945 |
| 44 | MP0002282_abnormal_trachea_morphology | 0.80790819 |
| 45 | MP0002971_abnormal_brown_adipose | 0.76117532 |
| 46 | MP0009763_increased_sensitivity_to | 0.75617143 |
| 47 | MP0008469_abnormal_protein_level | 0.74886103 |
| 48 | MP0005376_homeostasis/metabolism_phenot | 0.73162232 |
| 49 | MP0003690_abnormal_glial_cell | 0.66525890 |
| 50 | MP0002078_abnormal_glucose_homeostasis | 0.65953235 |
| 51 | MP0003011_delayed_dark_adaptation | 0.62549792 |
| 52 | MP0005084_abnormal_gallbladder_morpholo | 0.61500172 |
| 53 | MP0005409_darkened_coat_color | 0.60682215 |
| 54 | MP0000639_abnormal_adrenal_gland | 0.60555780 |
| 55 | MP0003879_abnormal_hair_cell | 0.59860637 |
| 56 | MP0004272_abnormal_basement_membrane | 0.57920618 |
| 57 | MP0009053_abnormal_anal_canal | 0.57535818 |
| 58 | MP0005395_other_phenotype | 0.54775376 |
| 59 | MP0006054_spinal_hemorrhage | 0.49283722 |
| 60 | MP0005164_abnormal_response_to | 0.48828017 |
| 61 | MP0005220_abnormal_exocrine_pancreas | 0.47657473 |
| 62 | MP0002168_other_aberrant_phenotype | 0.47627057 |
| 63 | MP0005023_abnormal_wound_healing | 0.47080255 |
| 64 | MP0004883_abnormal_blood_vessel | 0.46732765 |
| 65 | MP0005167_abnormal_blood-brain_barrier | 0.45420978 |
| 66 | MP0009780_abnormal_chondrocyte_physiolo | 0.45252077 |
| 67 | MP0003638_abnormal_response/metabolism_ | 0.44069903 |
| 68 | MP0005448_abnormal_energy_balance | 0.43894435 |
| 69 | MP0005334_abnormal_fat_pad | 0.43291007 |
| 70 | MP0009115_abnormal_fat_cell | 0.43113188 |
| 71 | MP0003186_abnormal_redox_activity | 0.41906539 |
| 72 | MP0003121_genomic_imprinting | 0.41716858 |
| 73 | MP0008872_abnormal_physiological_respon | 0.41010154 |
| 74 | MP0003953_abnormal_hormone_level | 0.40264405 |
| 75 | MP0005187_abnormal_penis_morphology | 0.39043789 |
| 76 | MP0003183_abnormal_peptide_metabolism | 0.38607453 |
| 77 | MP0002249_abnormal_larynx_morphology | 0.38226374 |
| 78 | MP0002933_joint_inflammation | 0.38172175 |
| 79 | MP0003632_abnormal_nervous_system | 0.38132585 |
| 80 | MP0001756_abnormal_urination | 0.37846081 |
| 81 | MP0005257_abnormal_intraocular_pressure | 0.36947261 |
| 82 | MP0000920_abnormal_myelination | 0.36352090 |
| 83 | MP0000249_abnormal_blood_vessel | 0.35996969 |
| 84 | MP0005535_abnormal_body_temperature | 0.35670543 |
| 85 | MP0003878_abnormal_ear_physiology | 0.34790396 |
| 86 | MP0005377_hearing/vestibular/ear_phenot | 0.34790396 |
| 87 | MP0003075_altered_response_to | 0.34662931 |
| 88 | MP0003567_abnormal_fetal_cardiomyocyte | 0.33665089 |
| 89 | MP0003329_amyloid_beta_deposits | 0.32306610 |
| 90 | MP0005266_abnormal_metabolism | 0.31959755 |
| 91 | MP0009764_decreased_sensitivity_to | 0.31401666 |
| 92 | MP0003941_abnormal_skin_development | 0.30956520 |
| 93 | MP0002909_abnormal_adrenal_gland | 0.30650660 |
| 94 | MP0001324_abnormal_eye_pigmentation | 0.30230940 |
| 95 | MP0004130_abnormal_muscle_cell | 0.30071018 |
| 96 | MP0002128_abnormal_blood_circulation | 0.29382430 |
| 97 | MP0003950_abnormal_plasma_membrane | 0.28910599 |
| 98 | MP0003115_abnormal_respiratory_system | 0.28331848 |
| 99 | MP0003633_abnormal_nervous_system | 0.27829039 |
| 100 | MP0002697_abnormal_eye_size | 0.27701215 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged partial thromboplastin time (HP:0003645) | 9.56514535 |
| 2 | Complement deficiency (HP:0004431) | 9.00244299 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 7.86365749 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 7.78489456 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.49578529 |
| 6 | Abnormality of complement system (HP:0005339) | 7.06667192 |
| 7 | Joint hemorrhage (HP:0005261) | 6.75593762 |
| 8 | Conjugated hyperbilirubinemia (HP:0002908) | 5.99802912 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 5.67882325 |
| 10 | Abnormality of the common coagulation pathway (HP:0010990) | 5.62867247 |
| 11 | Glomerulonephritis (HP:0000099) | 5.51803236 |
| 12 | Xanthomatosis (HP:0000991) | 4.95426016 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.65944973 |
| 14 | Hyperlipoproteinemia (HP:0010980) | 4.47537996 |
| 15 | Intrahepatic cholestasis (HP:0001406) | 4.47182866 |
| 16 | Spontaneous abortion (HP:0005268) | 4.45072706 |
| 17 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.09782132 |
| 18 | Hypercholesterolemia (HP:0003124) | 3.89790957 |
| 19 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.88170863 |
| 20 | Abnormality of the intrinsic pathway (HP:0010989) | 3.80806795 |
| 21 | Nephritis (HP:0000123) | 3.53237640 |
| 22 | Epidermoid cyst (HP:0200040) | 3.35618233 |
| 23 | Menorrhagia (HP:0000132) | 3.32317828 |
| 24 | Hemorrhage of the eye (HP:0011885) | 3.30229824 |
| 25 | Fat malabsorption (HP:0002630) | 3.23589250 |
| 26 | Vascular calcification (HP:0004934) | 3.18011416 |
| 27 | Gingival bleeding (HP:0000225) | 3.15458542 |
| 28 | Hypoalphalipoproteinemia (HP:0003233) | 3.08640743 |
| 29 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.06566137 |
| 30 | Mitral stenosis (HP:0001718) | 2.97353647 |
| 31 | Purpura (HP:0000979) | 2.93449776 |
| 32 | Hyperglycinemia (HP:0002154) | 2.88821456 |
| 33 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.80464753 |
| 34 | Cardiovascular calcification (HP:0011915) | 2.79351122 |
| 35 | Osteomalacia (HP:0002749) | 2.75020510 |
| 36 | Thrombophlebitis (HP:0004418) | 2.72980389 |
| 37 | Rickets (HP:0002748) | 2.66393334 |
| 38 | Abnormality of methionine metabolism (HP:0010901) | 2.66157446 |
| 39 | Acanthocytosis (HP:0001927) | 2.64948526 |
| 40 | Generalized aminoaciduria (HP:0002909) | 2.53983185 |
| 41 | Hepatocellular carcinoma (HP:0001402) | 2.51720612 |
| 42 | Hyperammonemia (HP:0001987) | 2.48708705 |
| 43 | Abnormality of glycine metabolism (HP:0010895) | 2.46211306 |
| 44 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.46211306 |
| 45 | Arthropathy (HP:0003040) | 2.43701832 |
| 46 | Hypophosphatemic rickets (HP:0004912) | 2.40518273 |
| 47 | Delayed CNS myelination (HP:0002188) | 2.36776182 |
| 48 | Abnormal tarsal ossification (HP:0008369) | 2.34281154 |
| 49 | Fair hair (HP:0002286) | 2.32072483 |
| 50 | Myocardial infarction (HP:0001658) | 2.27964836 |
| 51 | Pulmonary embolism (HP:0002204) | 2.21586295 |
| 52 | Abnormality of carpal bone ossification (HP:0006257) | 2.19510797 |
| 53 | Hyperglycinuria (HP:0003108) | 2.16608514 |
| 54 | Skin nodule (HP:0200036) | 2.15561025 |
| 55 | Hyperbilirubinemia (HP:0002904) | 2.11340473 |
| 56 | Poikilocytosis (HP:0004447) | 2.07702767 |
| 57 | Steatorrhea (HP:0002570) | 2.02832002 |
| 58 | Deep venous thrombosis (HP:0002625) | 11.5767624 |
| 59 | Enlarged kidneys (HP:0000105) | 1.94210054 |
| 60 | Increased serum pyruvate (HP:0003542) | 1.93917982 |
| 61 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.91557252 |
| 62 | Abnormality of serum amino acid levels (HP:0003112) | 1.91520180 |
| 63 | Abnormality of the Achilles tendon (HP:0005109) | 1.90856478 |
| 64 | Abnormality of nucleobase metabolism (HP:0010932) | 1.87850036 |
| 65 | Bifid scrotum (HP:0000048) | 1.87329234 |
| 66 | Hypoglycemic coma (HP:0001325) | 1.86078990 |
| 67 | Cholecystitis (HP:0001082) | 1.85470051 |
| 68 | Abnormal gallbladder physiology (HP:0012438) | 1.85470051 |
| 69 | Epistaxis (HP:0000421) | 1.80480395 |
| 70 | Reduced antithrombin III activity (HP:0001976) | 1.77221306 |
| 71 | Joint swelling (HP:0001386) | 1.76583805 |
| 72 | Flat acetabular roof (HP:0003180) | 1.75404860 |
| 73 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.74807627 |
| 74 | Hyperphosphaturia (HP:0003109) | 1.73894319 |
| 75 | Facial shape deformation (HP:0011334) | 1.73043586 |
| 76 | Potter facies (HP:0002009) | 1.73043586 |
| 77 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.72667382 |
| 78 | Abnormality of glycolysis (HP:0004366) | 1.70838147 |
| 79 | Cholelithiasis (HP:0001081) | 1.64851646 |
| 80 | Ketosis (HP:0001946) | 1.63549219 |
| 81 | Small epiphyses (HP:0010585) | 1.62878926 |
| 82 | Broad alveolar ridges (HP:0000187) | 1.62877942 |
| 83 | Hydroxyprolinuria (HP:0003080) | 1.62761402 |
| 84 | Abnormality of proline metabolism (HP:0010907) | 1.62761402 |
| 85 | Esophageal varix (HP:0002040) | 1.60964190 |
| 86 | Abnormal hand bone ossification (HP:0010660) | 1.59978478 |
| 87 | Abnormal gallbladder morphology (HP:0012437) | 1.57028579 |
| 88 | Abnormal ossification of hand bones (HP:0005921) | 1.57017450 |
| 89 | Glycosuria (HP:0003076) | 1.56997830 |
| 90 | Abnormality of urine glucose concentration (HP:0011016) | 1.56997830 |
| 91 | Neonatal hypoglycemia (HP:0001998) | 1.56617654 |
| 92 | Gangrene (HP:0100758) | 1.56140565 |
| 93 | Abnormality of the lumbar spine (HP:0100712) | 1.55118788 |
| 94 | Increased mean platelet volume (HP:0011877) | 1.54412868 |
| 95 | Abnormal delivery (HP:0001787) | 1.54190850 |
| 96 | Elevated alkaline phosphatase (HP:0003155) | 1.52969331 |
| 97 | Peritonitis (HP:0002586) | 1.52536689 |
| 98 | Increased serum ferritin (HP:0003281) | 1.52226612 |
| 99 | Blue irides (HP:0000635) | 1.51088563 |
| 100 | Abnormality of vitamin metabolism (HP:0100508) | 1.50237354 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FGFR4 | 7.17532046 |
| 2 | FGFR3 | 5.15905048 |
| 3 | ICK | 3.37693567 |
| 4 | ERN1 | 3.14898540 |
| 5 | PIK3CA | 3.10350138 |
| 6 | CDK12 | 2.83804154 |
| 7 | WNK4 | 2.72500313 |
| 8 | RIPK1 | 2.48261339 |
| 9 | FGFR2 | 2.25374870 |
| 10 | TRIB3 | 2.19787586 |
| 11 | TYRO3 | 2.12753884 |
| 12 | AKT3 | 2.03306510 |
| 13 | FGFR1 | 1.98453219 |
| 14 | PDGFRA | 1.87594079 |
| 15 | PRKAA2 | 1.72900727 |
| 16 | LATS1 | 1.70675735 |
| 17 | TYK2 | 1.62008542 |
| 18 | SIK1 | 1.57521165 |
| 19 | TGFBR2 | 1.54977481 |
| 20 | RET | 1.53604199 |
| 21 | MAPK11 | 1.53325811 |
| 22 | PKN2 | 1.51939253 |
| 23 | EIF2AK1 | 1.37830200 |
| 24 | DYRK1B | 1.37320687 |
| 25 | WNK1 | 1.35441853 |
| 26 | NEK9 | 1.34779680 |
| 27 | PDPK1 | 1.32384875 |
| 28 | SIK2 | 1.29004061 |
| 29 | PRKACG | 1.19206602 |
| 30 | MAP3K2 | 1.17837732 |
| 31 | ERBB2 | 1.17452177 |
| 32 | SGK223 | 1.05312092 |
| 33 | SGK494 | 1.05312092 |
| 34 | PDK1 | 1.03798986 |
| 35 | NTRK3 | 0.99389063 |
| 36 | EEF2K | 0.96480027 |
| 37 | DDR2 | 0.96176856 |
| 38 | EPHA4 | 0.88557647 |
| 39 | SGK3 | 0.87828296 |
| 40 | IGF1R | 0.83180402 |
| 41 | BCR | 0.82113856 |
| 42 | EPHA3 | 0.80237280 |
| 43 | CSF1R | 0.79801061 |
| 44 | SGK1 | 0.79059694 |
| 45 | CSNK1E | 0.78748855 |
| 46 | MAP2K4 | 0.78578132 |
| 47 | SGK2 | 0.77964248 |
| 48 | MAPKAPK3 | 0.77879495 |
| 49 | RPS6KB1 | 0.75507607 |
| 50 | PRKAA1 | 0.74654273 |
| 51 | BCKDK | 0.74327957 |
| 52 | CDK7 | 0.73234205 |
| 53 | IRAK3 | 0.70582572 |
| 54 | FGR | 0.70407154 |
| 55 | LATS2 | 0.69336404 |
| 56 | PRKCZ | 0.66618724 |
| 57 | CAMK1D | 0.66275407 |
| 58 | CDC42BPA | 0.64429459 |
| 59 | MST1R | 0.62074037 |
| 60 | PRKCG | 0.61952576 |
| 61 | MAP3K3 | 0.61456808 |
| 62 | BRSK2 | 0.61110278 |
| 63 | MAP3K5 | 0.60435535 |
| 64 | CDK6 | 0.59708858 |
| 65 | KSR2 | 0.56287865 |
| 66 | PRKG1 | 0.56075449 |
| 67 | CSNK1D | 0.55058918 |
| 68 | NLK | 0.53005526 |
| 69 | MAP3K1 | 0.52979025 |
| 70 | MAP2K3 | 0.52079746 |
| 71 | BRD4 | 0.51104788 |
| 72 | SRC | 0.50525870 |
| 73 | JAK1 | 0.48470280 |
| 74 | PIK3CG | 0.47283319 |
| 75 | MAP3K7 | 0.45401452 |
| 76 | RPS6KA3 | 0.45310937 |
| 77 | NEK1 | 0.45117041 |
| 78 | SCYL2 | 0.42423825 |
| 79 | MATK | 0.40693293 |
| 80 | MTOR | 0.39929562 |
| 81 | CDK4 | 0.38997494 |
| 82 | CSNK2A2 | 0.38978151 |
| 83 | BRSK1 | 0.38595334 |
| 84 | JAK2 | 0.37990147 |
| 85 | PRKACA | 0.36184058 |
| 86 | CSNK2A1 | 0.36078559 |
| 87 | NEK2 | 0.34663870 |
| 88 | MAP2K6 | 0.33710395 |
| 89 | STK39 | 0.33546084 |
| 90 | PTK6 | 0.33290282 |
| 91 | MAP3K6 | 0.30752507 |
| 92 | PRKCB | 0.30663014 |
| 93 | PRKACB | 0.29859061 |
| 94 | YES1 | 0.29485268 |
| 95 | CAMKK2 | 0.29428666 |
| 96 | NTRK2 | 0.29077003 |
| 97 | FER | 0.28680433 |
| 98 | MET | 0.26938861 |
| 99 | MAPK3 | 0.26246530 |
| 100 | PDGFRB | 0.25969608 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.70776850 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.44979871 |
| 3 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.82354555 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.52978328 |
| 5 | * Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.11387840 |
| 6 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.10938208 |
| 7 | * Retinol metabolism_Homo sapiens_hsa00830 | 3.02488647 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.86614776 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.62320201 |
| 10 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.62102722 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.62018791 |
| 12 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.58018049 |
| 13 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.47391338 |
| 14 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.47078791 |
| 15 | * Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.40338336 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 2.26126380 |
| 17 | * Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.21580463 |
| 18 | * Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.10531183 |
| 19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.02172381 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.86125977 |
| 21 | Bile secretion_Homo sapiens_hsa04976 | 1.72015106 |
| 22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.64223201 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.63322616 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.58884629 |
| 25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.58561598 |
| 26 | * Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.51494606 |
| 27 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.51224799 |
| 28 | * Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.51048481 |
| 29 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.41876244 |
| 30 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.41795082 |
| 31 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.41350182 |
| 32 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.36559549 |
| 33 | Peroxisome_Homo sapiens_hsa04146 | 1.28625876 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.26282228 |
| 35 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.19930846 |
| 36 | Prion diseases_Homo sapiens_hsa05020 | 1.19510798 |
| 37 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.19095126 |
| 38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.13318282 |
| 39 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.13196992 |
| 40 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.11865801 |
| 41 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.10046740 |
| 42 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.06653163 |
| 43 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.05424682 |
| 44 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.04303204 |
| 45 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.02622197 |
| 46 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.02385106 |
| 47 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.02133398 |
| 48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.98827186 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 0.97084684 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.88467179 |
| 51 | Carbon metabolism_Homo sapiens_hsa01200 | 0.86415450 |
| 52 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.84640125 |
| 53 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.84573795 |
| 54 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.82522398 |
| 55 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.72174965 |
| 56 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.71458450 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.61264837 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.61028870 |
| 59 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.59331480 |
| 60 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.47559072 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.42398933 |
| 62 | Pertussis_Homo sapiens_hsa05133 | 0.42295835 |
| 63 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.41123681 |
| 64 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.40708448 |
| 65 | Other glycan degradation_Homo sapiens_hsa00511 | 0.39149596 |
| 66 | Insulin resistance_Homo sapiens_hsa04931 | 0.33824876 |
| 67 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.33401271 |
| 68 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.30120630 |
| 69 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.27524012 |
| 70 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.25297323 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.25011060 |
| 72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22459731 |
| 73 | Sulfur relay system_Homo sapiens_hsa04122 | 0.20822858 |
| 74 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.18298623 |
| 75 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.14737107 |
| 76 | Galactose metabolism_Homo sapiens_hsa00052 | 0.13783244 |
| 77 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.08741807 |
| 78 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.08722448 |
| 79 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.06450584 |
| 80 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.06280713 |
| 81 | Mineral absorption_Homo sapiens_hsa04978 | 0.05294764 |
| 82 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.04538744 |
| 83 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.02347178 |
| 84 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.02218905 |
| 85 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.00802633 |
| 86 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.2396930 |
| 87 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.2053180 |
| 88 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.1555298 |
| 89 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1523981 |
| 90 | Folate biosynthesis_Homo sapiens_hsa00790 | -0.1497959 |
| 91 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1374871 |
| 92 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | -0.1185868 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1094790 |
| 94 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1085971 |
| 95 | Amoebiasis_Homo sapiens_hsa05146 | -0.0636185 |
| 96 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0510296 |
| 97 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0411908 |
| 98 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0362372 |
| 99 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0335701 |
| 100 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0221065 |

